MOLECULERA

Moleculera Labs is the sole provider of a testing panel which assists physicians in their diagnosis of autoimmune neuropsychiatric disorders, such as PANS and PANDAS. The Cunningham Panel™ is the first and only test of its kind in the world, and is the result of more than a decade of research and development... Moleculera Labs was founded by Dr. Madeleine Cunningham and Dr. Craig Shimasaki in response to a need for laboratory evidence supporting an underlying biologic root for seemingly unexplained neuropsychiatric symptoms. The company opened its clinical laboratory in April 2013 specifically to meet the testing needs of physicians treating individuals suffering from perplexing autoimmune neuropsychiatric disorders that are treatable... Moleculera Labs provides next-generation antibody tests that detect whether an autoimmune reaction is causing neurologic or psychiatric symptoms. The company is dedicated to improving the lives of children and adults impacted by infection-induced..

Also known as: Moleculera Labs, Moleculera Labs Company, Moleculera Labs, Inc.

Primary location: Oklahoma City United States